Type 2 Diabetes and Cardiometabolic Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Diabetes Res. Clin. Pract. 2024 Apr 02;[EPub Ahead of Print], NWS Chew, X Hui Pan, B Chong, C Chandramouli, M Muthiah, CSP LamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.